Transcription of NEW ZEALAND DATA SHEET - Medsafe
{{id}} {{{paragraph}}}
Example: bankruptcy
NEW ZEALAND DATA SHEET - Medsafe
NEW ZEALAND DATA SHEET . 1. PRODUCT NAME. cymevene 500 mg powder for intravenous infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION. Each vial contains 500 mg of ganciclovir (as ganciclovir sodium). After reconstitution with 10 mL of water for injections, each mL provides 50 mg of ganciclovir. cymevene is available as the sterile lyophilised powder containing ganciclovir sodium 543. mg equivalent to ganciclovir 500 mg and sodium 43 mg (2 mEq). Excipients with known effect: approximately 43 mg (2 mEq) sodium. For the full list of excipients, see section 3. PHARMACEUTICAL FORM. Powder for concentrate for solution for infusion (powder for infusion). White to off-white solid cake. Ganciclovir, when formulated as monosodium salt in the intravenous (IV) dosage form, is a white to off-white lyophilised powder.
NEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
Haemoglobin concentrations for the diagnosis, Haemoglobin, Recommendations for the treatment and, Diagnosis, International treatment guidelines for anaemia, Ferritin serum, plasma, Glucose Blood, serum, plasma, Total Iron Ferrozine, Total Iron - Ferrozine, INTEGRATED MANAGEMENT OF PREGNANCY, INTEGRATED MANAGEMENT OF PREGNANCY AND